A recent warning by the US Food and Drug Administration (FDA) on insulin pumps produced by Medtronic MiniMed underscores how insecure Internet-connected devices in the healthcare industry can put patients at risk.
Medtronic is recalling a number of its insulin pumps because they have a vulnerability that “allows a potential attacker with special technical skills and equipment to potentially send radiofrequency (RF) signals to a nearby insulin pump to change settings, impacting insulin delivery.” The FDA warns that the “risk of patient harm […] is significant” in the case of exploitation. Because the affected devices cannot be updated, Medtronic has opted for a product recall.
Read more: FDA Warns Of Dangerous Cybersecurity Hacking Risk With Connected Medical Devices
